Nedsat leverfunktion var forbundet med højere plasmakoncentrationer af M1, medens eksponeringen for moderstoffet var sammenlignelig med eksponeringen hos raske forsøgspersoner.
Impaired liver function was associated with higher exposure to M1 in plasma, whereas exposure to parent drug was comparable to exposure in healthy volunteers.